相关实验视频
Updated: Jun 28, 2025
11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
22.5K
帕金森病的先进疗法:对其适应症的个性化方法
Nils Schröter1, Bastian E A Sajonz2, Wolfgang H Jost3
1Department of Neurology and Clinical Neuroscience, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany. nils.schroeter@uniklinik-freiburg.de.
Journal of neural transmission (Vienna, Austria : 1996)
|April 13, 2024
概括
用于帕金森病的设备辅助疗法 (DAT),包括肠道凝,皮下注射和深度大脑刺激,提供各种益处. 由于疾病进展异质,对每个疗法进行个性化,持续的评估至关重要.
科学领域:
- 神经学 神经学
- 医疗器械 医疗器械
- 药物治疗 药物治疗
背景情况:
- 晚期帕金森病通常需要设备辅助疗法 (DAT),当标准药物治疗不足时.
- 目前的DAT选择包括莱沃多巴/卡比多巴肠凝 (LCIG),莱沃多巴/卡比多巴/恩塔卡肠凝 (LECIG),连续皮下阿波莫芬输液 (CSAI) 和深度大脑刺激 (DBS).
- 这些疗法在疗效,指示,侵入性,禁忌和副作用概况方面存在显著差异.
研究的目的:
- 批判性地评估和比较帕金森病的不同DAT.
- 倡导基于患者特异性疾病进展的DAT适合性的个性化和持续评估.
- 通过分析个体治疗概况来支持个性化治疗方法.
主要方法:
- 现有文献和临床经验的跨学科审查.
- 基于有效性 (运动和非运动缺陷),禁忌和周围程序考虑的DAT的比较分析.
- 强调帕金森病进展的异质性质.
主要成果:
- DAT表现出不同的疗效概况和患者适应性标准.
- 由于疾病进展的变化,对所有DAT的同时评估往往是不理想的.
- 在咨询期间进行个性化评估是必要的,以确定最佳的DAT时间和选择.
结论:
- 对DAT选择和时间的个性化方法对于有效的帕金森病管理至关重要.
- 需要持续对患者进行评估,以适应治疗的症状和疾病发展阶段.
- 这种评估有助于临床医生根据患者个体需求量身定制DAT策略.
相关概念视频
01:24Parkinson's Disease: Treatment
264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
01:15Parkinson's Disease: Overview
541
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
541
01:28Drug Therapy
43
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
43
01:22Alzheimer's Disease: Treatment
183
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
183
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:21EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K